ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.60
-0.34%
US Tech 100
17,650.00
0.05%
S&P 500
5,222.68
0.16%
US Dollar vs CAD
1.367
-0.05%
Bitcoin
61,228.43
0.71%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Journey Medical Corporation (DERM)

  7. Journey Medical Corporation (DERM) News

DERM

Journey Medical (DERM)

Journey Medical Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DERM
DateTimeSourceHeadlineSymbolCompany
05/07/20247:30AMGlobeNewswire Inc.Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024NASDAQ:DERMJourney Medical Corporation
05/01/20243:01PMGlobeNewswire Inc.Journey Medical Corporation Appoints Joseph Benesch as Chief Financial OfficerNASDAQ:DERMJourney Medical Corporation
04/25/20247:30AMGlobeNewswire Inc.Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024NASDAQ:DERMJourney Medical Corporation
03/21/20243:01PMGlobeNewswire Inc.Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate HighlightsNASDAQ:DERMJourney Medical Corporation
03/18/20247:30AMGlobeNewswire Inc.Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of RosaceaNASDAQ:DERMJourney Medical Corporation
03/15/20247:30AMGlobeNewswire Inc.Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024NASDAQ:DERMJourney Medical Corporation
03/13/20247:30AMGlobeNewswire Inc.Journey Medical Corporation to Participate in the 36th Annual ROTH ConferenceNASDAQ:DERMJourney Medical Corporation
03/11/20247:30AMGlobeNewswire Inc.Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual MeetingNASDAQ:DERMJourney Medical Corporation
02/23/20244:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DERMJourney Medical Corporation
01/05/20247:30AMGlobeNewswire Inc.Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat RosaceaNASDAQ:DERMJourney Medical Corporation
01/02/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
01/02/20243:05PMGlobeNewswire Inc.Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 MillionNASDAQ:DERMJourney Medical Corporation
12/15/20233:46PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DERMJourney Medical Corporation
12/08/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
12/06/20237:00AMGlobeNewswire Inc.Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat RosaceaNASDAQ:DERMJourney Medical Corporation
11/07/20233:45PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
11/07/20233:01PMGlobeNewswire Inc.Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:DERMJourney Medical Corporation
10/31/20237:30AMGlobeNewswire Inc.Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:DERMJourney Medical Corporation
10/20/20237:30AMGlobeNewswire Inc.Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) vs. Solodyn® (Minocycline Hydrochloride Extended-Release Tablets, 105 mg)NASDAQ:DERMJourney Medical Corporation
10/17/20233:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DERMJourney Medical Corporation
09/26/20238:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
09/19/20233:59PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
09/08/202312:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DERMJourney Medical Corporation
09/06/20237:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
09/06/20237:00AMGlobeNewswire Inc.Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbrexza® in South Korea and Other Asian NationsNASDAQ:DERMJourney Medical Corporation
08/18/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
08/14/20233:01PMGlobeNewswire Inc.Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:DERMJourney Medical Corporation
08/10/20233:45PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DERMJourney Medical Corporation
08/08/20233:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
08/08/20233:01PMGlobeNewswire Inc.Journey Medical Corporation Reports Second Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:DERMJourney Medical Corporation
 Showing the most relevant articles for your search:NASDAQ:DERM

Your Recent History

USOTC
DPMAY
Diploma (PK)
DOWI
DJTCGST
DJ Travel and Leisure Ti...
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved